COLUMBUS, Ohio – For the third consecutive time, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has been ranked as “exceptional” by the National Cancer Institute (NCI) — the highest rating provided — following a review of the university’s cancer program application for re-designation as a Comprehensive Cancer Center and a virtual site visit by a team of NCI surveyors.

The OSUCCC – James has retained its NCI designation as a Comprehensive Cancer Center — a designation it has maintained since 1976 through a competitive peer-review process that includes both written and on-site evaluation of the research program and infrastructure.

The re-designation will extend for five years and will provide the cancer program with an estimated $33 million Cancer Center Support Grant (CCSG) from the NCI. As the OSUCCC – James’ major extramural peer-reviewed funding source, the CCSG supports research programs, community outreach and engagement, education and training, clinical trial infrastructure, center senior leadership and administration, shared resource facilities, and program development.

NCI designation as a Comprehensive Cancer Center is the most prestigious recognition a cancer program can receive, providing an external and expert validation of the breadth and depth of an institution’s cancer research efforts and of how the institution translates those discoveries into excellent patient care.

“This exceptional ranking from the NCI is a tribute to the steadfast dedication of our team of more than 275 scientists and clinician-investigators working in laboratory, translational, clinical and population sciences to advancing cancer discoveries that will, ultimately, improve care at the bedside. We are honored to continue this important work that will lead us toward a cancer-free world,” says Raphael Pollock, MD, PhD, director of the OSUCCC and a surgical oncologist at The James.

To learn more about cancer research at the OSUCCC – James, visit cancer.osu.edu/research.

-30-

About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.

Media Contact: Amanda J. Harper
OSUCCC – James Media Relations
Direct Line: 614-685-5420
Central Media Relations: 614-293-3737
Amanda.Harper2@osumc.edu